Ablynx, Boehringer Ingelheim deal

Ablynx will receive €3 million ($4.4 million) in milestone payments from Boehringer under a 2007 deal to use Ablynx's Nanobody technology to discover, develop and commercialize up to 10 therapeutic pr...